Literature DB >> 20674433

Japanese encephalitis virus remains an important cause of encephalitis in Thailand.

Sonja J Olsen1, Krongkaew Supawat, Angela P Campbell, Surapee Anantapreecha, Sahas Liamsuwan, Supoch Tunlayadechanont, Anannit Visudtibhan, Somsak Lupthikulthum, Kanlaya Dhiravibulya, Akravudh Viriyavejakul, Punnee Vasiknanonte, Kiatsak Rajborirug, Veerachai Watanaveeradej, Chacrin Nabangchang, Janeen Laven, Olga Kosoy, Amanda Panella, Christine Ellis, Sununta Henchaichon, Nino Khetsuriani, Ann M Powers, Scott F Dowell, Marc Fischer.   

Abstract

BACKGROUND: Japanese encephalitis virus (JEV) is endemic in Thailand and prevention strategies include vaccination, vector control, and health education.
METHODS: Between July 2003 and August 2005, we conducted hospital-based surveillance for encephalitis at seven hospitals in Bangkok and Hat Yai. Serum and cerebrospinal (CSF) specimens were tested for evidence of recent JEV infection by immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) and a plaque reduction neutralization test (PRNT).
RESULTS: Of the 147 patients enrolled and tested, 24 (16%) had evidence of acute flavivirus infection: 22 (15%) with JEV and two (1%) with dengue virus. Of the 22 Japanese encephalitis (JE) cases, 10 (46%) were aged ≤ 15 years. The median length of hospital stay was 13 days; one 13-year-old child died. Ten percent of encephalitis patients enrolled in Bangkok hospitals were found to have JEV infection compared to 28% of patients enrolled in hospitals in southern Thailand (p < 0.01). Four (40%) of the 10 children with JE were reported as being vaccinated.
CONCLUSIONS: JEV remains an important cause of encephalitis among hospitalized patients in Thailand. The high proportion of JE among encephalitis cases is concerning and additional public health prevention efforts or expanded vaccination may be needed. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674433     DOI: 10.1016/j.ijid.2010.03.022

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  24 in total

Review 1.  Evolving Epidemiology of Japanese Encephalitis: Implications for Vaccination.

Authors:  John P Caldwell; Lin H Chen; Davidson H Hamer
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

2.  Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.

Authors:  Emmanuel Feroldi; Maria Rosario Capeding; Mark Boaz; Sophia Gailhardou; Claude Meric; Alain Bouckenooghe
Journal:  Hum Vaccin Immunother       Date:  2013-02-26       Impact factor: 3.452

3.  Seasonal abundance and potential of Japanese encephalitis virus infection in mosquitoes at the nesting colony of ardeid birds, Thailand.

Authors:  Tanasak Changbunjong; Thekhawet Weluwanarak; Namaoy Taowan; Parut Suksai; Tatiyanuch Chamsai; Poonyapat Sedwisai
Journal:  Asian Pac J Trop Biomed       Date:  2013-03

4.  Behavioral-biological surveillance of emerging infectious diseases among a dynamic cohort in Thailand.

Authors:  Kevin J Olival; Supaporn Wacharapluesadee; Su Yadana; Thaniwan Cheun-Arom; Hongying Li; Emily Hagan; Emma Mendelsohn; Alice Latinne; Stephanie Martinez; Opass Putcharoen; Janthira Homvijitkul; Onarnong Sathaporntheera; Nit Rattanapreeda; Pongtorn Chartpituck; Supalak Yamsakul; Krairoek Sutham; Supharoek Komolsiri; Sonjai Pornphatthananikhom; Sininat Petcharat; Weenassarin Ampoot; Leilani Francisco; Thiravat Hemachudha; Peter Daszak
Journal:  BMC Infect Dis       Date:  2022-05-16       Impact factor: 3.667

Review 5.  Risk assessment for Japanese encephalitis vaccination.

Authors:  Lance Turtle; Carolyn Driver
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

6.  Development and application of an antigen capture ELISA assay for diagnosis of Japanese encephalitis virus in swine, human and mosquito.

Authors:  Li Mei; Peng Wu; Jing Ye; Guangping Gao; Lin Shao; Shaomei Huang; Yaoming Li; Xiaohong Yang; Huanchun Chen; Shengbo Cao
Journal:  Virol J       Date:  2012-01-06       Impact factor: 4.099

7.  CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality.

Authors:  Szu-Ting Chen; Ren-Shyan Liu; Ming-Fang Wu; Yi-Ling Lin; Se-Yi Chen; David Tat-Wei Tan; Teh-Ying Chou; I-Shuen Tsai; Lei Li; Shie-Liang Hsieh
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

8.  Mosquito vector diversity across habitats in central Thailand endemic for dengue and other arthropod-borne diseases.

Authors:  Panpim Thongsripong; Amy Green; Pattamaporn Kittayapong; Durrell Kapan; Bruce Wilcox; Shannon Bennett
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

Review 9.  Japanese encephalitis - the prospects for new treatments.

Authors:  Lance Turtle; Tom Solomon
Journal:  Nat Rev Neurol       Date:  2018-04-26       Impact factor: 42.937

10.  Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus.

Authors:  Chonlatip Pipattanaboon; Tadahiro Sasaki; Mitsuhiro Nishimura; Chayanee Setthapramote; Pannamthip Pitaksajjakul; Pornsawan Leaungwutiwong; Kriengsak Limkittikul; Orapim Puiprom; Mikiko Sasayama; Panjaporn Chaichana; Tamaki Okabayashi; Takeshi Kurosu; Ken-Ichiro Ono; Pongrama Ramasoota; Kazuyoshi Ikuta
Journal:  Biologics       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.